FILE - Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in Denver on Saturday, March 6, 2021. On Thursday, May 5, 2022, U.S. regulators strictly limited who can receive this vaccine due to a rare but serious risk of blood clots. (AP Photo/David Zalubowski, File)
Advertisement
After several issues involving rare blood clots, the FDA will now limit who should receive the Johnson & Johnson vaccine.
Jamie Jackson is an Emmy-nominated television and radio broadcaster who has served American Urban Radio Networks since 2015. He previously covered the Obama and Trump administrations as a White House Correspondent and Pool Reporter for AURN News. Jamie hosted a national PBS television special in 2023 and over the years has worked as a TV news anchor and local NPR host for stations across the country. His work has been honored by numerous organizations, including the NAACP and the Virginia Farm Bureau.